Biomedtracker: 開発中医薬品をFDA承認確率で評価, ターゲット市場の実像を...

2020 Deal-Making Roundup

21 Sep 2021

Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

Topic drug-review Coronavirus

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetr...

Q3 2021 Outlook Report

27 Aug 2021

What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

Topic drug-review

ターゲット市場の実像をつかむ

Top 10 Best-Selling Drugs of 2020

02 Jul 2021

One hundred billion dollars. That is the combined revenue of the top 10 pharmaceuticals in 2020, marking the first year in which this threshold has been crossed.

Topic drug-review drug-pricing

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Glenmark Debuts Favipiravir For COVID-19 In India

27 Nov 2020

Glenmark has received the go-ahead in India for and launched its low-priced favipiravir product for mild to moderate COVID-19 under an accelerated approval process.

Topic Coronavirus drug-review

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

What Did US FDA Do Wrong In Its Review Of Aducanumab AdCom Members Have A List

17 Nov 2020

Committee members rebuked FDA for its positive review of Biogen’s Alzheimer’s disease drug, objecting to its ‘terrifically one-sided’ analysis of data, the short shrift given the contrary conclusions of its own statistician, and its interpretation of a dosing study to support the sole positive Phase III study.

Topic advisory committees drug-review fda

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース, Datamonitor He...

Top 10 Best-Selling Drugs of 2019

23 Oct 2020

In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

Topic Drug Review Diseases

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Massive Reallocation of UK Rapporteurships Likely As EMA Plans For Future; UK’s Interim Role Uncertain

25 Aug 2020

If Brexit means the UK no longer plays a part in the EU drug regulatory system, responsibility for the ongoing oversight of almost one in four of all the human medicines that have ever been approved under the centralized procedure will have to be reassigned from the UK to other member states. What Brexit means for the UK’s role as a key player in the regulatory system in the meantime is the subject of speculation.

Topic Brexit Drug Review Life Cycle Management

Pharmaprojects: 医薬品開発パイプラインのデータベース

世界の医薬品R&D最新動向・ホワイトペーパー

By Ian Lloyd 15 May 2020

世界の医薬品産業における研究開発トレンドを検証する年次ホワイトペーパー『Pharma R&D Annual Review 2020』が発行されました。1980年以来、弊社が追跡してきた世界の医薬品情報の蓄積を駆使して、会社別、治療領域別、疾病別、標的および剤型別にパイプラインを検証し、業界トレンドを評価しました。

Topic drug-development-landscape drug-review research